What is Peutz‑Jeghers syndrome and should it be considered in a 19‑year‑old male presenting with jejunal intussusception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peutz-Jeghers Syndrome and Jejunal Intussusception in Young Adults

Peutz-Jeghers syndrome (PJS) should absolutely be considered in this 19-year-old male with jejunal intussusception, as intussusception is the most common acute complication of PJS in young patients, occurring in 50% of cases by age 20 years. 1

What is Peutz-Jeghers Syndrome?

PJS is an autosomal dominant genetic disorder caused by germline mutations in the STK11/LKB1 gene, characterized by hamartomatous polyps throughout the gastrointestinal tract and distinctive mucocutaneous melanin pigmentation. 1

Key Diagnostic Features

The diagnosis can be established with any ONE of the following criteria: 1

  • Hamartomatous polyp(s) PLUS at least 2 of: labial melanin deposits, family history of PJS, or small bowel polyposis 1
  • Two or more PJS polyps 1
  • Any number of PJS polyps with a family history of PJS in a close relative 1
  • Characteristic mucocutaneous pigmentation with family history 1

Distinctive Clinical Characteristics

Mucocutaneous pigmentation (present in >95% of patients): 1

  • Dark brown or blue-brown macules, 1-5 mm in size 1
  • Located on vermilion border of lips (94%), buccal mucosa (66%), hands (74%), feet (62%) 1
  • Critical pitfall: Pigmentation typically appears in infancy but fades in late adolescence and adulthood, so absence in a 19-year-old does NOT exclude PJS 1
  • Unlike common freckles, PJS pigmentation crosses the vermilion border and appears on buccal mucosa 1

Hamartomatous polyps: 1

  • Distinctive histology with branching smooth muscle extending into the polyp, arborizing pattern, cystic gland dilatation, and normal overlying epithelium 1
  • Most commonly found in small bowel and colon 1
  • Can appear anywhere in the GI tract except esophagus 2

Why This Matters for Your 19-Year-Old Patient

Intussusception is THE hallmark acute complication of PJS in young patients: 1

  • Occurs in 15% of patients by age 10 years 1
  • Occurs in 50% of patients by age 20 years 1
  • Caused by hamartomatous polyps serving as lead points 3, 4
  • Can be life-threatening, causing bleeding, obstruction, or bowel infarction 1

Critical diagnostic consideration: 4, 5

  • Multiple intussusceptions can occur simultaneously in PJS patients 4, 5
  • The entire small bowel must be examined intraoperatively to exclude additional intussusceptions 5

Immediate Clinical Actions

During surgical intervention for intussusception: 5

  • Examine the ENTIRE small bowel for additional intussusceptions 5
  • Send resected specimen for histopathology to identify hamartomatous polyp features 3
  • Look for characteristic histologic features: hamartomatous architecture, arborizing smooth muscle, cystic glands 1

Post-operative evaluation to confirm PJS diagnosis: 1

  • Perform detailed physical examination for mucocutaneous pigmentation on lips, buccal mucosa, hands, feet, perianal region 1
  • Obtain detailed family history for PJS, early-onset cancers, or similar pigmentation 1
  • Arrange genetic testing for STK11/LKB1 mutations (detected in 66-94% of PJS cases) 1
  • Schedule upper and lower endoscopy to identify additional polyps throughout GI tract 3

Long-Term Cancer Surveillance Requirements

PJS patients face dramatically elevated cancer risks that mandate lifelong surveillance: 1

  • Cumulative cancer risk: 1-2% by age 20, >30% by age 50, >80% by age 70 1
  • Gastrointestinal cancers: Colorectal, pancreatic, stomach, small intestine 1
  • Breast cancer: Significantly elevated risk requiring early screening 1
  • Gynecologic cancers: Ovarian sex cord tumors with annular tubules (SCTAT), mucinous ovarian tumors, cervical adenocarcinoma 1
  • Testicular tumors: Large-cell calcifying Sertoli cell tumors (LCCSCT) 1

Surveillance protocol starting immediately: 1

  • Colonoscopy with polypectomy every 2 years 1
  • Upper GI endoscopy every 1-3 years starting at age 18 1
  • Annual pelvic examination and Pap test (for females) starting at ages 18-20 1
  • Annual pelvic ultrasound (for females) 1
  • Testicular examination for males 1

Genetic and Family Implications

Inheritance pattern: 6

  • Autosomal dominant with variable penetrance 6
  • 70% have positive family history, but 30% represent de novo mutations 6
  • Critical pitfall: Absence of family history does NOT exclude PJS 6

Genetic testing recommendations: 1

  • STK11/LKB1 mutation testing should be performed 1
  • Detection rate is 66-94% even with modern techniques 1
  • Negative genetic testing does NOT exclude clinical diagnosis of PJS 1

Epidemiology

Incidence: 1 in 50,000 to 1 in 200,000 live births 1, 6 Demographics: Affects all racial groups and both sexes equally 6 Average age at diagnosis: 23 years in males, 26 years in females 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Peutz-Jeghers syndrome in a woman presenting as intussusception: A case report.

International journal of surgery case reports, 2021

Research

Peutz-Jeghers syndrome with germline mutation of STK11.

Annals of surgical treatment and research, 2014

Guideline

Peutz-Jeghers Syndrome Demographics and Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the management and surveillance recommendations for a patient with Peutz-Jeghers syndrome?
What is the management plan for Peutz-Jeghers syndrome?
What is Puetz-Jeghers syndrome?
Does a normal colonoscopy performed at age 9 rule out Peutz‑Jeghers syndrome or jejunal hamartomatous polyps?
What is the management approach for Peutz-Jeghers syndrome?
In a 19‑year‑old male with jejunal intussusception, how common is spontaneous resolution?
What is the first‑line immunosuppressive agent and its dosing for interstitial lung disease associated with systemic autoimmune rheumatic diseases such as systemic sclerosis, inflammatory myopathy, rheumatoid arthritis, mixed connective tissue disease, and Sjögren’s syndrome?
In an adult over 30 with mild hyperglycemia and normal or slightly elevated body‑mass index who has been presumed to have type 2 diabetes, how should I confirm latent autoimmune diabetes in adults (LADA) and what is the recommended initial management?
How should I counsel parents of a child with an isolated cleft palate who are hesitant about a genetics evaluation to encourage referral?
What is the recommended assessment and treatment protocol for alcohol withdrawal in an adult who has recently reduced or stopped heavy drinking?
In a female patient admitted with enteric fever who has hemoglobin 8.2 g/dL, serum iron 30 µg/dL, total iron‑binding capacity 340 µg/dL, and ferritin 340 ng/mL without bleeding or jaundice, how should these findings be interpreted?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.